Shareholding7 Nov 2026, 03:30 pm
Nirma Ltd Sells 36.8 Lakh Shares of Alivus Life Sciences
AI Summary
Nirma Limited has sold 36,80,000 equity shares of Alivus Life Sciences Limited, representing 2.99% of the total shareholding. Following this sale, Nirma's holding in Alivus Life Sciences has reduced from 74.73% to 71.74% (or 74.54% to 71.56% on a diluted basis). The transaction occurred on November 6, 2026, via the open market. The total equity share capital of Alivus Life Sciences remains Rs. 24,59,34,562.
Key Highlights
- Nirma Ltd sold 36,80,000 equity shares of Alivus Life Sciences.
- The sale represents a 2.99% decrease in Nirma's shareholding.
- Nirma's post-sale holding in Alivus Life Sciences is 71.74%.
- The transaction was conducted on the open market.
- The seller, Nirma Ltd, is a promoter group entity.
Price Impact
More from ALIVUS